These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 16924793)
1. [The effects of cholesterol-lowering therapy on the results of coronary arterial stenting in patients with chronic forms of coronary heart disease]. Arablinskiĭ AV; Zakharova OV; Ioseliani DG Klin Med (Mosk); 2006; 84(7):13-6. PubMed ID: 16924793 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients. Sharma R; Mahajan M; Singh B; Bal BS; Kant R J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006 [TBL] [Abstract][Full Text] [Related]
3. [The role of cytokines in restenosing coronary stents and the efficiency of its secondary prophylaxis with statins]. Tepliakov AT; Rybal'chenko EV Klin Med (Mosk); 2008; 86(8):32-9. PubMed ID: 18819344 [TBL] [Abstract][Full Text] [Related]
4. [Coronary stenting in patients with chronic forms of coronary heart disease]. Arablinskiĭ AV Klin Med (Mosk); 2004; 82(11):20-6. PubMed ID: 15656393 [TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome. Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539 [TBL] [Abstract][Full Text] [Related]
6. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level. Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547 [TBL] [Abstract][Full Text] [Related]
7. Current questions regarding the use of statins in patients with coronary heart disease. Rallidis LS; Lekakis J; Kremastinos DT Int J Cardiol; 2007 Nov; 122(3):188-94. PubMed ID: 17399827 [TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566 [TBL] [Abstract][Full Text] [Related]
9. Role of statin therapy in the coronary bypass patient. Lazar HL Ann Thorac Surg; 2004 Aug; 78(2):730-40. PubMed ID: 15276569 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study). LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H; Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314 [TBL] [Abstract][Full Text] [Related]
11. [On the use of statins in patients with chronic cardiac insufficiency]. Ol'binskaia LI; Sizova ZhM; Zakharova VL Klin Med (Mosk); 2007; 85(9):40-4. PubMed ID: 18038566 [TBL] [Abstract][Full Text] [Related]
12. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
14. Patterns and predictors of statin use after coronary artery bypass graft surgery. Kulik A; Levin R; Ruel M; Mesana TG; Solomon DH; Choudhry NK J Thorac Cardiovasc Surg; 2007 Oct; 134(4):932-8. PubMed ID: 17903510 [TBL] [Abstract][Full Text] [Related]
15. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. Settergren M; Böhm F; Rydén L; Pernow J Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323 [TBL] [Abstract][Full Text] [Related]
16. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321 [TBL] [Abstract][Full Text] [Related]
17. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441 [TBL] [Abstract][Full Text] [Related]
18. Treating average cholesterol levels in patients with coronary heart disease. Lindbloom EJ J Fam Pract; 1999 Feb; 48(2):94-5. PubMed ID: 10037537 [No Abstract] [Full Text] [Related]
19. Continuation of statin treatment and all-cause mortality: a population-based cohort study. Shalev V; Chodick G; Silber H; Kokia E; Jan J; Heymann AD Arch Intern Med; 2009 Feb; 169(3):260-8. PubMed ID: 19204217 [TBL] [Abstract][Full Text] [Related]
20. The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting. Perler BA Semin Vasc Surg; 2007 Dec; 20(4):252-8. PubMed ID: 18082842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]